These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16858744)

  • 1. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries.
    Arraras JI; Kuljanic-Vlasic K; Bjordal K; Yun YH; Efficace F; Holzner B; Mills J; Greimel E; Krauss O; Velikova G;
    Psychooncology; 2007 Mar; 16(3):249-54. PubMed ID: 16858744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a questionnaire to evaluate the information needs of cancer patients: the EORTC questionnaire.
    Arraras JI; Wright S; Greimel E; Holzner B; Kuljanic-Vlasic K; Velikova G; Eisemann M; Visser A;
    Patient Educ Couns; 2004 Aug; 54(2):235-41. PubMed ID: 15288920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients.
    Arraras JI; Greimel E; Sezer O; Chie WC; Bergenmar M; Costantini A; Young T; Vlasic KK; Velikova G
    Eur J Cancer; 2010 Oct; 46(15):2726-38. PubMed ID: 20674333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire.
    Arraras JI; Greimel E; Chie WC; Sezer O; Bergenmar M; Costantini A; Young T; Kuljanic K; Velikova G;
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):281-6. PubMed ID: 21671697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires.
    Pezzilli R; Morselli-Labate AM; Fantini L; Campana D; Corinaldesi R
    Dig Liver Dis; 2007 Dec; 39(12):1077-86. PubMed ID: 17692582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
    Greimel E; Nordin A; Lanceley A; Creutzberg CL; van de Poll-Franse LV; Radisic VB; Galalae R; Schmalz C; Barlow E; Jensen PT; Waldenström AC; Bergmark K; Chie WC; Kuljanic K; Costantini A; Singer S; Koensgen D; Menon U; Daghofer F;
    Eur J Cancer; 2011 Jan; 47(2):183-90. PubMed ID: 20851597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison.
    Brédart A; Mignot V; Rousseau A; Dolbeault S; Beauloye N; Adam V; Elie C; Léonard I; Asselain B; Conroy T
    Patient Educ Couns; 2004 Aug; 54(2):207-12. PubMed ID: 15288916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery.
    Singer S; Kuhnt S; Momenghalibaf A; Stuhr C; Dimmel-Hennersdorf U; Köhler U; Einenkel J
    Gynecol Oncol; 2010 Jan; 116(1):82-7. PubMed ID: 19836828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
    Carlson LE; Bultz BD; Morris DG
    Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
    Morita S; Kaptein AA; Oba K; Sakamoto J
    Psychooncology; 2008 May; 17(5):474-9. PubMed ID: 17847126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.